Status:
UNKNOWN
A Prospective Controlled Study of Serum suPAR in the CsA-treated FSGS Patients
Lead Sponsor:
Guangdong Provincial People's Hospital
Conditions:
FSGS
Eligibility:
All Genders
14-70 years
Brief Summary
The purpose of this study is to determine whether the improved responsiveness to treatment achieved by CsA in patients with steroid-resistant or steroid-dependent FSGS could be explained by CsA's inhi...
Eligibility Criteria
Inclusion
- Age at entry is between 14 and 70 years
- biopsy-proven primary FSGS
- proteinuria \>=3 g/day
- without corticosteroids or CsA treatment before entry
Exclusion
- Chronic Inflammatory Diseases
- malignant tumor
- diabetes mellitus
- contraindications for the treatment of corticosteroids or CsA treatment
- untolerate to or unwilling to accept corticosteroids or CsA treatment
Key Trial Info
Start Date :
January 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2019
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT01468493
Start Date
January 1 2011
End Date
January 1 2019
Last Update
April 24 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nephrology Dept.,Guangdong General Hospital
Guangzhou, Guangdong, China, 510080